Delivery Order SPE2DB24D2109-SPE2DB25FHXPW
- Not listed
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,409.14, is for the delivery of PAXLOVID 300/150-100MG (SEVERE) UU 11S, a medication used to treat severe cases of COVID-19. The award does not have a set-aside designation, indicating it was open to full and open competition. The delivery order has a firm fixed-price...
- The Defense Logistics Agency awarded a $8,924.51 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Qualipita 60 mg tablets (30-count units) under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is set to conclude by July 29, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,337.55 to AmerisourceBergen Drug Corp for the supply of Qualiptа 30 mg tablets (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,154.79 to AmerisourceBergen Drug Corp for the supply of Qualiptа 60 mg tablets (30-count) with a firm fixed price structure. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRUQAP 160 mg tablets (16-count units) valued at $15,959.30, with a firm fixed price structure and an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 1, 2025, with performance occurring at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $2,069.16 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of AMLOD-VALSA-HCTZ 5-160-25 MG in 30-count packaging. The contract, which is non-set-aside and competitively awarded on a firm fixed price basis, is scheduled for completion by August 5, 2025, with performance to occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $4,027.02 delivery order to AmerisourceBergen Drug Corp for Quilpta 60 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- This delivery order, valued at $142,433.37, was awarded to AmerisourceBergen Drug Corp on July 21, 2025, under a firm fixed-price arrangement with an ultimate completion date of July 22, 2025. The contract is executed through the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense responsible for pharmaceutical and medical product distribution to military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a $31,343.79 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for pharmaceutical and medical supply products. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by July 29, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania facility. As a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award was issued on July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXPWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Paxlovid 300/150 mg tablets (severe dosage) under a firm fixed-price contract valued at $1,061.66. The delivery order, which was not set-aside, was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This order represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical products to military healthcare systems, the Defense Health Agency, and other government entities. The company's federal contract portfolio demonstrates consistent competitive success across numerous therapeutic domains, positioning it as a key supplier within the Defense Logistics Agency's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/31/25 |